View Filing Data

Print Document View Excel Document

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2019	May 02, 2019
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Trading Symbol	GTX
Entity Registrant Name	Garrett Motion Inc.
Entity Central Index Key	0001735707
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		74,578,460

CONSOLIDATED AND COMBINED INTERIM STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
Net sales (Note 4)	$ 835	$ 915
Cost of goods sold	639	704
Gross profit	196	211
Selling, general and administrative expenses	60	63
Other expense, net (Note 6)	19	42
Interest expense	16	2
Non-operating expense (income)	4	(9)
Income before taxes	97	113
Tax expense (Note 7)	24	55
Net income	$ 73	$ 58
Earnings per common share
Basic	$ 0.98	$ 0.78
Diluted	$ 0.97	$ 0.78
Weighted average common shares outstanding
Basic	74,229,627	74,070,852
Diluted	75,379,228	74,070,852

CONSOLIDATED AND COMBINED INTERIM STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 73	$ 58
Foreign exchange translation adjustment	59	(177)
Defined benefit pension plan adjustment, net of tax (Note 15)	1
Changes in fair value of effective cash flow hedges, net of tax (Note 14)	3	(7)
Total other comprehensive (loss) income, net of tax	63	(184)
Comprehensive income (loss)	$ 136	$ (126)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

CONSOLIDATED AND COMBINED INTERIM BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 207	$ 196
Accounts, notes and other receivables – net (Note 8)	790	750
Inventories – net (Note 9)	181	172
Other current assets	61	71
Total current assets	1,239	1,189
Investments and long-term receivables	35	39
Property, plant and equipment – net	424	438
Goodwill	193	193
Deferred income taxes	159	165
Other assets (Note 10)	122	80
Total assets	2,172	2,104
Current liabilities:
Accounts payable	881	916
Current maturities of long-term debt	23	23
Obligations payable to Honeywell, current (Note 17)	124	127
Accrued liabilities (Note 11)	433	426
Total current liabilities	1,461	1,492
Long-term debt	1,542	1,569
Deferred income taxes	29	27
Obligations payable to Honeywell (Note 17)	1,350	1,399
Other liabilities (Note 12)	242	210
Total liabilities	4,624	4,697
COMMITMENTS AND CONTINGENCIES (Note 17)
EQUITY (DEFICIT)
Additional paid-in capital	10	5
Retained earnings	(2,598)	(2,671)
Accumulated other comprehensive income (Note 15)	136	73
Total stockholders' deficit	(2,452)	(2,593)
Total liabilities and stockholders' deficit	$ 2,172	$ 2,104

CONSOLIDATED AND COMBINED INTERIM BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2019	Dec. 31, 2018
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares, issued	74,634,286	74,070,852
Common stock, shares, outstanding	74,583,259	74,019,825

CONSOLIDATED AND COMBINED INTERIM STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 73	$ 58
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Deferred income taxes	3	28
Depreciation	19	18
Amortization of deferred issuance costs	2
Foreign exchange (gain) loss	7	(8)
Stock compensation expense	5	7
Pension expense	1	2
Other	4	1
Changes in assets and liabilities:
Accounts, notes and other receivables	(43)	(113)
Receivables from related parties		2
Inventories	(14)	4
Other assets	13	(29)
Accounts payable	(24)	27
Payables to related parties		(19)
Accrued liabilities	12	27
Obligations payable to Honeywell	(21)
Asbestos related liabilities		2
Other liabilities	(1)	5
Net cash provided by (used for) operating activities	36	12
Cash flows from investing activities:
Expenditures for property, plant and equipment	(21)	(28)
Increase in marketable securities		(21)
Decrease in marketable securities		202
Other	1	2
Net cash provided by (used for) investing activities	(20)	155
Cash flows from financing activities:
Net increase (decrease) in Invested deficit		812
Proceeds from revolving credit facility	140
Payments of revolving credit facility	(140)
Payments of long-term debt	(6)
Payments related to related party notes payable		(493)
Net change related to cash pooling and short-term notes		(482)
Other	1
Net cash provided by (used for) financing activities	(5)	(163)
Effect of foreign exchange rate changes on cash and cash equivalents		7
Net increase (decrease) in cash and cash equivalents	11	11
Cash and cash equivalents at beginning of period	196	300
Cash and cash equivalents at end of period	$ 207	$ 311

CONSOLIDATED AND COMBINED INTERIM STATEMENTS OF EQUITY (DEFICIT) (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Invested Deficit	Accumulated Other Comprehensive Income/(loss)
Beginning balance at Dec. 31, 2017	$ (2,195)				$ (2,433)	$ 238
Net income	58				58
Other comprehensive income, net of tax	(184)					(184)
Change in Invested deficit	1,080				1,080
Ending balance at Mar. 31, 2018	(1,241)				$ (1,295)	54
Beginning balance at Dec. 31, 2018	(2,593)		$ 5	$ (2,671)		73
Beginning balance, Shares at Dec. 31, 2018		74
Net income	73			73
Other comprehensive income, net of tax	63					63
Stock-based compensation	5		5
Stock based compensation, Shares		1
Ending balance at Mar. 31, 2019	$ (2,452)		$ 10	$ (2,598)		$ 136
Ending balance, Shares at Mar. 31, 2019		75

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Background and Revision of Previously Issued Consolidated and Combined Interim Financial Statements for the Three Months Ended March 31, 2018

3 Months Ended

Mar. 31, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Background and Revision of Previously Issued Consolidated and Combined Interim Financial Statements for the Three Months Ended March 31, 2018

Note 1A. Background and Revision of Previously Issued Consolidated and Combined Interim Financial Statements for the Three Months Ended March 31, 2018

Background

Garrett Motion Inc. (the “Company” or “Garrett”) designs, manufactures and sells highly engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (“OEMs”) and the global vehicle independent aftermarket, as well as automotive software solutions. We are a global technology leader with significant expertise in delivering products across gasoline and diesel propulsion systems and hybrid and fuel cell powertrains.

On October 1, 2018, the Company became an independent publicly-traded company through a pro rata distribution by Honeywell International Inc. (“Former Parent” or “Honeywell”) of 100% of the then-outstanding shares of Garrett to Honeywell’s stockholders (the “Spin-Off”). Each Honeywell stockholder of record received one share of Garrett common stock for every 10 shares of Honeywell common stock held on the record date. Approximately 74 million shares of Garrett common stock were distributed on October 1, 2018 to Honeywell stockholders. In connection with the Spin-Off, Garrett´s common stock began trading “regular-way” under the ticker symbol “GTX” on the New York Stock Exchange on October 1, 2018.

The Spin-Off was completed pursuant to a Separation and Distribution Agreement and other agreements with Honeywell related to the Spin-Off, including but not limited to an indemnification and reimbursement agreement (the “Indemnification and Reimbursement Agreement”) and a tax matters agreement (the “Tax Matters Agreement”). Refer to Note 17, Commitments and Contingencies for additional details related to the Indemnification and Reimbursement Agreement and Tax Matters Agreement.

Unless the context otherwise requires, references to “Garrett,” “we,” “us,” “our,” and “the Company” refer to (i) Honeywell’s Transportation Systems Business (the “Transportation Systems Business” or the “Business”) prior to the Spin-Off and (ii) Garrett Motion Inc. and its subsidiaries following the Spin-Off, as applicable.

Revision of Previously Issued Consolidated and Combined Interim Financial Statements for the Three Months Ended March 31, 2018

In August 2018, the Business, as part of Honeywell, determined that it had not appropriately applied the provisions of ASC 450, Contingencies, in measuring its asbestos liabilities related to unasserted Bendix claims. For the three months ended March 31, 2018, the Company now reflects the epidemiological projections through 2059 rather than a five-year time horizon when estimating the liability for unasserted Bendix-related asbestos claims.

In light of the foregoing, the Company has revised our combined interim financial statements for the three months ended March 31, 2018 included in our Amendment No. 1 to Form 10, as confidentially filed with the Securities and Exchange Commission (“SEC”) on June 8, 2018 to reflect the effects of the revised method for estimating the total liability for unasserted Bendix-related asbestos claims.

The Consolidated and Combined Interim Statements of Operations, Consolidated and Combined Interim Statements of Comprehensive Income and Consolidated and Combined Interim Statements of Cash Flows for the three months ended March 31, 2018 included in this Form 10-Q were updated to reflect the revision.

The following tables identify each financial statement line item affected by the revision.

	Three Months Ended, March 31, 2018
Unaudited Consolidated and Combined Interim Statement of Operations (Millions)	Previously Reported			Adjustment			As Revised
	Unaudited			Unaudited			Unaudited
Other expense, net	$	44		$	(2	)	$	42
Income before taxes	$	111		$	2		$	113
Tax expense	$	55		$	—		$	55
Net income	$	56		$	2		$	58

	Three Months Ended, March 31, 2018
Unaudited Consolidated and Combined Interim Statement of Comprehensive Income (Millions)	Previously Reported			Adjustment			As Revised
	Unaudited			Unaudited			Unaudited
Net Income	$	56		$	2		$	58
Comprehensive (loss) income	$	(128	)	$	2		$	(126	)

	Three Months Ended, March 31, 2018
	Unaudited			Unaudited			Unaudited
Unaudited Consolidated and Combined Interim Statement of Cash Flows (Millions)	Previously Reported			Adjustment			As Revised
Net Income	$	56		$	2		$	58
Changes in assets and liabilities: Asbestos-related liabilities	$	4		$	(2	)	$	2
Net cash provided by operating activities	$	12		$	—		$	12
Net increase in Invested deficit	$	812		$	—		$	812
Net cash (used for) provided by financing activities	$	(163	)	$	—		$	(163	)

Basis of Presentation

3 Months Ended

Mar. 31, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis of Presentation

Note 1B. Basis of Presentation

Basis of Presentation

Prior to the Spin-Off on October 1, 2018, our historical financial statements were prepared on a stand-alone combined basis and were derived from the consolidated financial statements and accounting records of Honeywell. Accordingly, for periods prior to October 1, 2018, our financial statements are presented on a combined basis and for the periods subsequent to October 1, 2018 are presented on a consolidated basis (collectively, the historical financial statements for all periods presented are referred to as “Consolidated and Combined Interim Financial Statements”). The Consolidated and Combined Interim Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Asbestos-related expenses, net of probable insurance recoveries, are presented within Other expense, net in the Consolidated and Combined Interim Statement of Operations. Honeywell is subject to certain asbestos-related and environmental-related liabilities, primarily related to its legacy Bendix business. In conjunction with the Spin-Off, certain operations that were part of the Bendix business, along with the ownership of the Bendix trademark, as well as certain operations that were part of other legacy elements of the Business, were transferred to us. For the periods prior to the Spin-Off, these Consolidated and Combined Interim Financial Statements reflect an estimated liability for resolution of pending and future asbestos-related and environmental liabilities primarily related to the legacy Bendix business, calculated as if we were responsible for 100% of the Bendix asbestos-liability payments. However, this recognition model differs from the recognition model applied subsequent to the Spin-Off, with the difference recognized through equity as of the Spin-Off date. In periods subsequent to the Spin-Off, the accounting for the majority of our asbestos-related liability payments and accounts payable reflect the terms of the Indemnification and Reimbursement Agreement with Honeywell entered into on September 12, 2018, under which we are required to make payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. The Indemnification and Reimbursement Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement.

The Consolidated and Combined Interim Financial Statements are unaudited; however, in the opinion of management, they contain all the adjustments (consisting of those of a normal recurring nature) considered necessary to state fairly the financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP applicable to interim periods. The Consolidated and Combined Interim Financial Statements should be read in conjunction with the audited annual Consolidated and Combined Financial Statements for the year ended December 31, 2018 included in our Annual Report on Form 10-K, as filed with the SEC on March 1, 2019 (our “2018 Form 10-K”). The results of operations and cash flows for the three months ended March 31, 2019 should not necessarily be taken as indicative of the entire year.

We report our quarterly financial information using a calendar convention: the first, second and third quarters are consistently reported as ending on March 31, June 30 and September 30. It has been our practice to establish actual quarterly closing dates using a predetermined fiscal calendar, which requires our businesses to close their books on a Saturday in order to minimize the potentially disruptive effects of quarterly closing on our business processes. The effects of this practice are generally not significant to reported results for any quarter and only exist within a reporting year. In the event that differences in actual closing dates are material to year-over-year comparisons of quarterly or year-to-date results, we will provide appropriate disclosures. Our actual closing dates for the three months ended March 31, 2019 and 2018 were March 30, 2019 and March 31, 2018, respectively.

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

The accounting policies of the Company are set forth in Note 2 to the audited annual Consolidated and Combined Financial Statements for the year ended December 31, 2018 included in our 2018 Form 10-K. We include herein certain updates to those policies.

Leases - Lessee accounting policy

For the periods beginning January 1, 2019, right-of-use (“ROU”) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date of a lease (the “commencement date”) based on the present value of lease payments over the lease term. We determine if an arrangement is a lease at inception. Operating leases are included in Other assets, Accrued liabilities, and Other liabilities in our Consolidated and Combined Balance Sheets. No finance leases have been recognized.

As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments are expensed in the period in which they occur.

We have lease agreements with lease and non-lease components, which are generally accounted for separately. For machinery and equipment, we account for the lease and non-lease components as a single lease component.

We account for short-term leases by recognizing lease payments in net income on a straight-line basis over the lease term and will not recognize any ROU assets and lease liabilities on the Consolidated and Combined Balance Sheet.

For the periods prior to January 1, 2019, we accounted for leases in accordance with ASC 840.

Recently Adopted Accounting Pronouncements

Effective January 1, 2019, the Company adopted the new lease accounting standard using the modified retrospective transition option of applying the new standard at the adoption date while electing not to recast comparative periods in the transition. In addition, we elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed us to carry forward the historical lease classification. In adopting the new leases standard, the Company has applied the practical expedients as per ASC 842-10-65-1(f) and (g). Adoption of the new standard resulted in the recording of additional lease assets and lease liabilities of $34 million as of January 1, 2019. The adoption of this standard did not have a material impact related to existing leases and as a result, a cumulative-effect adjustment was not recorded.

In February 2018, the FASB issued guidance that allows for an entity to elect to reclassify the income tax effects on items within Accumulated other comprehensive income resulting from The Tax Cuts and Jobs Act (“Tax Act”) to retained earnings. The guidance is effective for fiscal years beginning after December 15, 2018. Upon adoption, the Company did not elect to reclassify the stranded income tax effects of the Tax Act from accumulated other comprehensive income to retained earnings.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13), which requires measurement and recognition of expected credit losses for financial assets held. ASU 2016-13 will be effective for us in our first quarter of fiscal 2020, and earlier adoption is permitted beginning in the first quarter of fiscal 2019. We are currently evaluating the impact of the guidance on our Consolidated and Combined Financial Statements.

Related Party Transactions with Honeywell

3 Months Ended

Mar. 31, 2019

Note 3. Related Party Transactions with Honeywell

Subsequent to Spin-Off

Following the Spin-Off, Honeywell is no longer considered a related party.

Prior to Spin-Off

Prior to the Spin-Off, the Consolidated and Combined Interim Financial Statements were prepared on a stand-alone basis and are derived from the Consolidated Interim Financial Statements and accounting records of Honeywell.

Honeywell provided certain services, such as legal, accounting, information technology, human resources and other infrastructure support, on behalf of the Business. The cost of these services has been allocated to the Business on the basis of the proportion of revenues. The Business and Honeywell consider the allocations to be a reasonable reflection of the benefits received by the Business. During the three months ended March 31, 2018, the Business was allocated $29 million of general corporate expenses incurred by Honeywell, and such amounts are included within Selling, general and administrative expenses in the Consolidated and Combined Interim Statements of Operations. As certain expenses reflected in the Consolidated and Combined Interim Financial Statements for the three months ended March 31, 2018 include allocations of corporate expenses from Honeywell, these statements could differ from those that would have been prepared had the Business operated on a stand-alone basis.

The Company received interest income for related party notes receivables of less than $1 million for the three months ended March 31, 2018. Additionally, the Company incurred interest expense for related party notes payable of $1 million for the three months ended March 31, 2018.

Net transfers to and from Honeywell are included within Invested deficit on the Consolidated and Combined Interim Statements of Equity. The components of the net transfers to and from Honeywell for the three months ended March 31, 2018 are as follows:

	Three Months Ended March 31,
	2018
General financing activities	$	1,841
Distribution to Former Parent		(799	)
Unbilled corporate allocations		29
Stock compensation expense and other compensation awards		7
Pension expense		2
Total net decrease in Invested deficit	$	1,080

Revenue Recognition and Contracts with Customers

3 Months Ended

Mar. 31, 2019

Revenue From Contract With Customer [Abstract]

Revenue Recognition and Contracts with Customers

Note 4. Revenue Recognition and Contracts with Customers

Disaggregated Revenue

Sales by region (determined based on country of shipment) and channel are as follows:

	Three months ended March 31, 2019
	OEM		Aftermarket		Other		Total
United States	$	83	$	45	$	1	$	129
Europe		429		37		12		478
Asia		199		13		7		219
Other International		4		5		—		9
	$	715	$	100	$	20	$	835

	Three months ended March 31, 2018⁽¹⁾
	OEM		Aftermarket		Other		Total
United States	$	89	$	43	$	1	$	133
Europe	463		41		17		521
Asia	230		12		8		250
Other International	5		6			—	11
	$	787	$	102	$	26	$	915

(1)	The revenue information was previously disaggregated between OEM and Aftermarket and is now disaggregated between OEM, Aftermarket, and Other. As a result, the prior period presented was recast to conform to the current year presentation.

Contract Balances

The following table summarizes our contract assets and liabilities balances:

	2019
Contract assets—January 1	$	5
Contract assets—March 31		6
Change in contract assets—Increase/(Decrease)	$	1
Contract liabilities—January 1	$	(2	)
Contract liabilities—March 31		(2	)
Change in contract liabilities—(Increase)/Decrease	$	—

Research and Development

3 Months Ended

Mar. 31, 2019

Research And Development [Abstract]

Research and Development

Note 5. Research and Development

Garrett conducts research and development activities, which consist primarily of the development of new products and product applications. R&D costs are charged to expense as incurred. Such costs are included in Cost of goods sold as follows:

	Three Months Ended March 31,
	2019		2018
Research and development costs	$	32	$	31
Engineering-related expenses		3		2
	$	35	$	33

Other Expense, Net

3 Months Ended

Mar. 31, 2019

Other Income And Expenses [Abstract]

Other Expense, Net

Note 6. Other Expense, Net

	Three Months Ended March 31,
	2019		2018
Indemnification related — post Spin-Off	$	19	$	—
Asbestos related, net of probable insurance recoveries		—		41
Environmental remediation, non-active sites		—		1
	$	19	$	42

Income Taxes

3 Months Ended

Mar. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes

Note 7. Income Taxes

The effective tax rate decreased for the three months ended March 31, 2019, as compared to the three months ended March 31, 2018, primarily due to a $25 million tax expense attributable to currency impacts for withholding taxes on undistributed foreign earnings which was recorded during the three months ended March 31, 2018.

The effective tax rate for the three months ended March 31, 2019 was higher than the U.S. federal statutory rate of 21% due primarily to non-deductible indemnity expenses partially offset by non-U.S. earnings taxed at lower rates.

The effective tax rate for the three months ended March 31, 2018 was higher than the U.S. federal statutory rate of 21% due primarily to non-deductible asbestos expenses and tax expense attributable to currency impacts for withholding taxes on undistributed foreign earnings, partially offset by non-U.S. earnings taxed at lower rates.

On December 22, 2017, the U.S. enacted the Tax Act which instituted fundamental changes to the taxation of multinational corporations. The Tax Act changed the taxation of foreign earnings by implementing a dividend exemption system, expansion of the current anti-deferral rules, a minimum tax on low-taxed foreign earnings and new measures to deter base erosion. The Tax Act also included a permanent reduction in the corporate tax rate to 21%, repeal of the corporate alternative minimum tax, expensing of capital investment and limitation of the deduction for interest expense.

The effective tax rate can vary from quarter to quarter due to the tax impacts from the resolution of income tax audits, changes in tax laws, employee share-based payments, internal restructurings, pension mark-to-market adjustments, and the current uncertainty regarding state taxes including potential responses of state taxing authorities to legislative changes within the Tax Act.

Accounts, Notes and Other Receivables—Net

3 Months Ended

Mar. 31, 2019

Receivables [Abstract]

Accounts, Notes and Other Receivables—Net

Note 8. Accounts, Notes and Other Receivables—Net

	March 31, 2019			December 31, 2018
Trade receivables	$	641		$	593
Notes receivables		77			93
Other receivables		77			67
	$	795		$	753
Less—Allowance for doubtful accounts		(5	)		(3	)
	$	790		$	750

Trade Receivables include $20 million and $5 million of unbilled balances as of March 31, 2019 and December 31, 2018, respectively. These amounts are billed in accordance with the terms of customer contracts to which they relate. Unbilled receivables include $6 million and $5 million of contract assets as of March 31, 2019 and December 31, 2018, respectively. See Note 4, Revenue Recognition and Contracts with Customers.

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details

Inventories-Net

3 Months Ended

Mar. 31, 2019

Inventory Disclosure [Abstract]

Inventories-Net

Note 9. Inventories—Net

	March 31, 2019			December 31, 2018
Raw materials	$	112		$	112
Work in process		20			19
Finished products		72			64
	$	204		$	195
Less—Reserves		(23	)		(23	)
	$	181		$	172

Other Assets

3 Months Ended

Mar. 31, 2019

Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]

Other Assets

Note 10. Other Assets

	March 31,		December 31,
	2019		2018
Advanced discounts to customers, non-current	$	53	$	56
Operating right-of-use assets (Note 13)		37		—
Undesignated cross-currency swap at fair value		25		16
Other		7		8
	$	122	$	80

Accrued Liabilities

3 Months Ended

Mar. 31, 2019

Accrued Liabilities Current [Abstract]

Accrued Liabilities

Note 11. Accrued Liabilities

	March 31, 2019		December 31, 2018
Customer pricing reserve	$	115	$	107
Compensation, benefit and other employee related		60		71
Repositioning		7		15
Product warranties and performance guarantees		35		32
Taxes		106		113
Advanced discounts from suppliers, current		18		17
Customer advances and deferred income^(a)		23		14
Accrued interest		11		6
Short-term lease liability (Note 13)		9		—
Other (primarily operating expenses)		49		51
	$	433	$	426

(a)	Customer advances and deferred income include $2 million of contract liabilities as of March 31, 2019 and December 31, 2018. See Note 4 Revenue Recognition and Contracts with Customers.

The Company accrued repositioning costs related to projects to optimize our product costs and to right-size our organizational structure. Expenses related to the repositioning accruals are included in Cost of goods sold in our Consolidated and Combined Interim Statements of Operations.

	Severance Costs			Exit Costs		Total
Balance at December 31, 2017	$	53		$	7	$	60
Charges		2			—		2
Usage—cash		(3	)		—		(3	)
Foreign currency translation		2			—		2
Balance at March 31, 2018	$	54		$	7	$	61

	Severance Costs			Exit Costs			Total
Balance at December 31, 2018	$	13		$	2		$	15
Charges		1			—			1
Usage—cash		(2	)		(2	)		(4	)
Adjustments and reclassifications		(6	)		1			(5	)
Foreign currency translation		—			—			—
Balance at March 31, 2019	$	6		$	1		$	7

Other Liabilities

3 Months Ended

Mar. 31, 2019

Other Liabilities Disclosure [Abstract]

Other Liabilities

Note 12. Other Liabilities

	March 31,		December 31,
	2019		2018
Pension and other employee related	$	69	$	71
Advanced discounts from suppliers		61		63
Uncertain tax positions		63		59
Long-term lease liability (Note 13)		27		—
Other		22		17
	$	242	$	210

Leases

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Leases

Note 13. Leases

We have operating leases for real estate and machinery and equipment. Our leases have remaining lease terms of up to 12 years, some of which include options to extend the leases for up to two years, and some of which include options to terminate the leases within the year.

The components of lease expense are as follows:

Three Months Ended

March 31, 2019

Operating lease cost

Supplemental cash flow information related to operating leases is follows:

	Three Months Ended March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:	$
Operating cash outflows from operating leases		3
Right-of-use assets obtained in exchange for lease obligations:
Operating leases		5

Supplemental balance sheet information related to operating leases is follows:

	March 31, 2019
Other assets	$	37
Accrued liabilities		9
Other liabilities		27

		March 31, 2019
Weighted-average lease term		6.45
Weighted-average discount rate		6.34

Maturities of operating lease liabilities were as follows:

	March 31, 2019
2019	$	9
2020		8
2021		5
2022		5
2023		4
Thereafter		13
Total lease payments		44
Less imputed interest		(8	)
	$	36

As of December 31, 2018, in accordance with the previous lease standard, ASC 840, future minimum lease payments under operating leases having initial non-cancellable lease terms in excess of one year were as follows:

	December 31, 2018
2019	$	12
2020		8
2021		5
2022		4
2023		4
Thereafter		15
	$	48

Financial Instruments and Fair Value Measures

3 Months Ended

Mar. 31, 2019

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Financial Instruments and Fair Value Measures

Note 14. Financial Instruments and Fair Value Measures

Our credit, market and foreign currency risk management policies are described in Note 16, Financial Instruments and Fair Value Measures, of the notes to the audited annual Consolidated and Combined Financial Statements for the year ended December 31, 2018 included in our 2018 Form 10-K. At March 31, 2019 and December 31, 2018, we had contracts with aggregate gross notional amounts of $967 million and $838 million, respectively, to exchange foreign currencies, principally the U.S. Dollar, Swiss Franc, British Pound, Euro, Chinese Yuan, Japanese Yen, Mexican Peso, New Romanian Leu, Czech Crown, Australian Dollar and Korean Won.

Financial and nonfinancial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2019 and December 31, 2018:

					Fair Value
	Notional Amounts				Assets					Liabilities
	March 31, 2019		December 31, 2018		March 31, 2019		December 31, 2018			March 31, 2019		December 31, 2018
Designated forward currency exchange contracts	$	257	$	—	$	3	$	—	^(b)	$	—	$	—
Undesignated instruments:
Undesignated cross-currency swap		423		425		25		16	^(a)		—		—
Undesignated forward currency exchange contracts		287		413		2		4	^(b)		1		1	^(c)
		710		838		27		20			1		1
	$	967	$	838	$	30	$	20		$	1	$	1

(a)

Recorded within Other assets in the Company’s Consolidated and Combined Balance Sheets

(b)

Recorded within Other current assets in the Company’s Consolidated and Combined Balance Sheets

(c)

Recorded within Accrued liabilities in the Company’s Consolidated and Combined Balance Sheets

During the first quarter of 2019, the Company entered into forward currency exchange contracts to mitigate exposure to foreign currency exchange rate volatility and the associated impact on earnings related to forecasted foreign currency commitments. These forward currency exchange contracts are assessed as highly effective and are designated as cash flow hedges. Gains and losses on derivatives qualifying as cash flow hedges are recorded in Accumulated other comprehensive income (loss) until the underlying transactions are recognized in earnings.

On September 27, 2018, the Company entered into a floating-floating cross-currency swap contract to hedge the foreign currency exposure from foreign currency-denominated debt which will mature on September 27, 2025. The gain or loss on this derivative instrument is recognized in earnings and included in Non-operating expense (income). For the three months ended March 31, 2019, gains recorded in Non-operating expense (income) under the cross-currency swap contract were $8 million.

The foreign currency exchange and cross-currency swap contracts are valued using market observable inputs. As such, these derivative instruments are classified within Level 2. The assumptions used in measuring fair value of the cross-currency swap are considered level 2 inputs, which are based upon market observable interest rate curves, cross currency basis curves, credit default swap curves, and foreign exchange rates.

The carrying value of Cash and cash equivalents, Account receivables, notes and other receivables, and Account payables contained in the Consolidated and Combined Balance Sheets approximates fair value.

The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:

	March 31, 2019
	Carrying Value		Fair Value
Long-term debt and related current maturities	$	1,565	$	1,564

The Company determined the fair value of certain of its long-term debt and related current maturities utilizing transactions in the listed markets for similar liabilities. As such, the fair value of the long-term debt and related current maturities is considered level 2.

Accumulated Other Comprehensive Income (Loss)

3 Months Ended

Mar. 31, 2019

Accumulated Other Comprehensive Income Loss Net Of Tax [Abstract]

Accumulated Other Comprehensive Income (Loss)

Note 15. Accumulated Other Comprehensive Income (Loss)

Changes in Accumulated Other Comprehensive Income (Loss) by Component

	Foreign Exchange Translation Adjustment			Changes in Fair Value of Effective Cash Flow Hedges			Pension Adjustments			Total Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2017	$	284		$	(35	)	$	(11	)	$	238
Other comprehensive income (loss) before reclassifications		(177	)		(19	)		—			(196	)
Amounts reclassified from accumulated other comprehensive income (loss)		—			12			—			12
Net current period other comprehensive income (loss)		(177	)		(7	)		—			(184	)
Balance at March 31, 2018	$	107		$	(42	)	$	(11	)	$	54

	Foreign Exchange Translation Adjustment		Changes in Fair Value of Effective Cash Flow Hedges		Pension Adjustments			Total Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2018	$	86	$	—	$	(13	)	$	73
Other comprehensive income (loss) before reclassifications		59		3		—			62
Amounts reclassified from accumulated other comprehensive income (loss)		—		—		1			1
Net current period other comprehensive income (loss)		59		3		1			63
Balance at March 31, 2019	$	145	$	3	$	(12	)	$	136

Earnings Per Share

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Earnings Per Share

Note 16. Earnings Per Share

On October 1, 2018, the date of consummation of the Spin-Off, 74,070,852 shares of the Company’s common stock were distributed to Honeywell stockholders of record as of September 18, 2018 who held their shares through the Distribution Date. Basic and Diluted EPS for all historical periods prior to the Spin-Off reflect the number of distributed shares, or 74,070,852 shares.

The details of the earnings per share calculations for the three months ended March 31, 2019 and 2018 are as follows:

	Three Months Ended March 31,
	2019		2018
Basic
Net Income	$	73	$	58
Weighted average common shares outstanding		74,229,627		74,070,852
EPS – Basic	$	0.98	$	0.78

	Three Months Ended March 31,
	2019		2018
Diluted
Net Income	$	73	$	58
Weighted average common shares outstanding – Basic		74,229,627		74,070,852
Dilutive effect of unvested RSUs and other contingently issuable shares		1,149,601		—
Weighted average common shares outstanding – Diluted		75,379,228		74,070,852
EPS – Diluted	$	0.97	$	0.78

Diluted EPS is computed based upon the weighted average number of common shares outstanding for the period plus the dilutive effect of common stock equivalents using the treasury stock method and the average market price of our common stock for the period.

The diluted earnings per share calculations exclude the effect of stock options when the options’ assumed proceeds exceed the average market price of the common shares during the period. For the three months ended March 31, 2019, the weighted number of stock options excluded from the computations was 146,652. These stock options were outstanding at March 31, 2019.

Commitments and Contingencies

3 Months Ended

Mar. 31, 2019

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 17. Commitments and Contingencies

Obligations payable to Honeywell

Honeywell is a defendant in asbestos-related personal injury actions mainly related to its legacy Bendix friction materials (“Bendix”) business. The Bendix business manufactured automotive brake linings that contained chrysotile asbestos in an encapsulated form. Claimants consist largely of individuals who allege exposure to asbestos from brakes from either performing or being in the vicinity of individuals who performed brake replacements. Certain operations that were part of the Bendix business were transferred to Garrett.

In connection with the Spin-Off, we entered into an Indemnification and Reimbursement Agreement with Honeywell on September 12, 2018. As of the Spin-Off date of October 1, 2018, we are obligated to make payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. Pursuant to the terms of this Indemnification and Reimbursement Agreement, we are responsible for paying to Honeywell such amounts, up to a cap of an amount equal to the Euro-to-U.S. dollar exchange rate determined by Honeywell as of a date within two business days prior to the date of the Distribution (1.16977 USD = 1 EUR) equivalent of $175 million in respect of such liabilities arising in any given calendar year. The payments that we are required to make to Honeywell pursuant to the terms of this agreement will not be deductible for U.S. federal income tax purposes. The Indemnification and Reimbursement Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement. During the first quarter of 2019, we paid Honeywell the Euro-equivalent of $38 million in connection with the Indemnification and Reimbursement Agreement.

On September 12, 2018, we also entered into a Tax Matters Agreement with Honeywell (the “Tax Matters Agreement”), which governs the respective rights, responsibilities and obligations of Honeywell and us after the Spin-Off with respect to all tax matters (including tax liabilities, tax attributes, tax returns and tax contests). The Tax Matters Agreement generally provides that, following the Spin-Off date of October 1, 2018, we are responsible and will indemnify Honeywell for all taxes, including income taxes, sales taxes, VAT and payroll taxes, relating to Garrett for all periods, including periods prior to the completion date of the Spin-Off. Among other items, as a result of the mandatory transition tax imposed by the Tax Cuts and Jobs Act, one of our subsidiaries is required to make payments to a subsidiary of Honeywell in the amount representing the net tax liability of Honeywell under the mandatory transition tax attributable to us, as determined by Honeywell. We currently estimate that our aggregate payments to Honeywell with respect to the mandatory transition tax will be $240 million. Under the terms of the Tax Matters Agreement, we are required to pay this amount in Euros, without interest, in five annual installments, each equal to 8% of the aggregate amount, followed by three additional annual installments equal to 15%, 20% and 25% of the aggregate amount, respectively. Following the Spin-Off in October of 2018, we paid our first annual installment in that month. Subsequently, our annual installments will be paid in April of each year. On April 1, 2019, we paid our second annual installment of the Euro-equivalent of $18 million.

In addition, the Tax Matters Agreement addresses the allocation of liability for taxes incurred as a result of restructuring activities undertaken to effectuate the Spin-Off. The Tax Matters Agreement also provides that we are required to indemnify Honeywell for certain taxes (and reasonable expenses) resulting from the failure of the Spin-Off and related internal transactions to qualify for their intended tax treatment under U.S. federal, state and local income tax law, as well as foreign tax law. Further, the Tax Matters Agreement also imposes certain restrictions on us and our subsidiaries (including restrictions on share issuances, redemptions or repurchases, business combinations, sales of assets and similar transactions) that are designed to address compliance with Section 355 of the Internal Revenue Code of 1986, as amended, and are intended to preserve the tax-free nature of the Spin-Off.

The following table summarizes our Obligation payable to Honeywell related to these agreements:

	2019
	Asbestos and environmental			Tax Matters			Total
Beginning of year	$	1,244		$	282		$	1,526
Accrual for update to estimated liability		—			2			2
Legal fees expensed		15			—			15
Payments to Honeywell		(38	)		—			(38	)
Currency translation adjustment		(25	)		(6	)		(31	)
End of period	$	1,196		$	278		$	1,474

Current		106			18			124
Non-current		1,090			260			1,350
Total	$	1,196		$	278		$	1,474

Asbestos Matters

For the periods prior to the Spin-Off, these Consolidated and Combined Interim Financial Statements reflect an estimated liability for resolution of pending and future asbestos-related and environmental liabilities primarily related to the Bendix legacy Honeywell business, calculated as if we were responsible for 100% of the Bendix asbestos-liability payments. However, this recognition model differs from the recognition model applied subsequent to the Spin-Off as outlined above. In periods subsequent to the Spin-Off, the accounting for the majority of our asbestos-related liability payments and accounts payable reflect the terms of the Indemnification and Reimbursement Agreement with Honeywell entered into on September 12, 2018, under which we are required to make payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. The Indemnification and Reimbursement Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement.

The following tables present information regarding Bendix related asbestos claims activity:

	Three Months Ended March 31,			Year Ended December 31,
Claims Activity	2019			2018
Claims Unresolved at the beginning of the period		6,209			6,280
Claims Filed		631			2,430
Claims Resolved		(626	)		(2,501	)
Claims Unresolved at the end of the period		6,214			6,209

	Three Months Ended March 31,		Years Ended December 31,
Disease Distribution of Unresolved Claims	2019		2018
Mesothelioma and Other Cancer Claims		3,028		2,949
Nonmalignant Claims		3,186		3,260
Total Claims		6,214		6,209

Honeywell has experienced average resolutions per claim excluding legal costs as follows:

	Years Ended December 31,
	2018		2017		2016		2015		2014
			(in whole dollars)
Malignant claims	$	55,300	$	56,000	$	44,000	$	44,000	$	53,500
Nonmalignant claims	$	4,700	$	2,800	$	4,485	$	100	$	120

It is not possible to predict whether resolution values for Bendix-related asbestos claims will increase, decrease or stabilize in the future.

Other Matters

We are subject to other lawsuits, investigations and disputes arising out of the conduct of our business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee benefit plans, intellectual property, and environmental, health and safety matters. We recognize a liability for any contingency that is probable of occurrence and reasonably estimable. We continually assess the likelihood of adverse judgments of outcomes in these matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts. To date, no such matters are material to the Consolidated and Combined Interim Statements of Operations.

Pension Benefits

3 Months Ended

Mar. 31, 2019

Compensation And Retirement Disclosure [Abstract]

Pension Benefits

Note 18. Pension Benefits

Following the Spin-Off, we sponsor several funded U.S. and non-U.S. defined benefit pension plans. Significant plans outside of the U.S. are in Switzerland and Ireland. Other pension plans outside of the U.S. are not material to the Company either individually or in the aggregate.

Our general funding policy for qualified defined benefit pension plans is to contribute amounts at least sufficient to satisfy regulatory funding standards. We are not required to make any contributions to our U.S. pension plan in 2019. We expect to make contributions of cash and/or marketable securities of approximately $6 million to our non-U.S. pension plans to satisfy regulatory funding standards in 2019, of which $1 million has been contributed through the first three months of the year.

For periods prior to the Spin-Off, we only accounted for our pension plan in Ireland as a defined benefit pension plan. Our other pension plans were accounted for as multiemployer plans as further described below.

Net periodic benefit costs for our significant defined benefit plans include the following components:

	Three Months Ended
	U.S. Plans March 31,			Non-U.S. Plans⁽¹⁾ March 31,
	2019			2019			2018
Service cost		—		1			$	1
Interest cost	1			1				—
Expected return on plan assets		(1	)		(1	)		(1	)
Amortization of prior service (credit)		—			—			—
		—		1			$	—

(1)	For the periods prior to the Spin-Off, only the pension plan in Ireland is reflected as a non-U.S. defined benefit pension plan as all other pension plans were accounted for as multiemployer plans. Following the Spin-Off, the defined benefit pension plan in Switzerland is also reflected.

For our U.S. defined benefit pension plan from the date of the Spin-Off, we estimate the service and interest cost components of net period benefit (income) cost by utilizing a full yield curve approach in the estimation of these cost components by applying the specific spot rates along the yield curve used in the determination of the pension benefit obligation to their underlying projected cash flows. This approach provides a more precise measurement of service and interest costs by improving the correlation between projected cash flows and their corresponding spot rates. For our Switzerland and Ireland defined benefit pension plans until 2019, we estimated such cost components utilizing a single weighted-average discount rate derived from the yield curve used to measure the pension benefit obligation. In 2019, we updated the approach for estimating the service and interest cost components of net period benefit (income) cost for the Switzerland and Ireland plans to the full yield curve approach.

Prior to the completion of the Spin-Off, certain Garrett employees participated in defined benefit pension plans (the “Shared Plans”) sponsored by Honeywell which includes participants of other Honeywell subsidiaries and operations. We accounted for our participation in the Shared Plans as multiemployer benefit plans. Accordingly, we did not record an asset or liability to recognize the funded status of the Shared Plans. The related pension expense was based on annual service cost of active Garrett participants and reported within Cost of goods sold in the Combined Statements of Operations. The pension expense specifically identified for the active Garrett participants in the Shared Plans for the three months ended March 31, 2018 was $2 million.

China Variable Interest Entity

3 Months Ended

Mar. 31, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

China Variable Interest Entity

Note 19. China Variable Interest Entity

On September 20, 2018 in preparation of the Spin-Off, we entered into an agreement by and between Honeywell International Inc. and Garrett Motion Inc. (the “China Purchase Agreement”) in which Honeywell agreed to sell to Garrett 100% of the equity interests of Honeywell Transportation Investment (China) Co., Ltd. (“Garrett China”) consisting of our primary operations in China, in exchange for upfront consideration of 8,444,077 shares of our common stock. No further consideration from Garrett is due. The transfer of the equity interests in Garrett China from Honeywell to Garrett will occur following the current share lock-up period, one year from the date of the agreement.

Garrett China is considered a variable interest entity for which Garrett is the primary beneficiary because the China Purchase Agreement provides Garrett, prior to the transfer of the equity interests, control to direct the management and operation of Garrett China as well as all economic benefits and losses. The intent of the agreement is to place Garrett in the same position as if it already owned 100% of the equity interests of Garrett China. As the agreement was effective prior to the Spin-Off date while the Company and Garrett China were under common control of Honeywell, the assets and liabilities of Garrett China are recognized at their carrying amounts. Additionally, the related operations of Garrett China were included in our Consolidated and Combined Statements of Operations for the three months ended March 31, 2018 which were prepared on a carve-out basis.

The following table summarizes the consolidated assets and liabilities of Garrett China:

	March 31,		December 31,
	2019		2018
	(Dollars in millions)
ASSETS
Current assets:
Cash and cash equivalents	$	114	$	70
Accounts, notes and other receivables—net		211		224
Inventories—net		21		19
Total current assets		346		313
Property, plant and equipment—net		68		67
Deferred income taxes		21		20
Other assets		1		1
Total assets	$	436	$	401
LIABILITIES
Current liabilities:
Accounts payable	$	261	$	261
Accrued liabilities		83		77
Total current liabilities		344		338
Other liabilities		12		13
Total liabilities	$	356	$	351

Net sales from Garrett China were $116 million and $130 million for the three months ended March 31, 2019 and 2018, respectively. Related expenses primarily consisted of Costs of Goods Sold of $79 million and $88 million, Selling, general and administrative expenses of $3 million and $2 million and Tax expense of $7 million and $10 million for the three months ended March 31, 2019 and 2018, respectively.

Summary of Significant Accounting Policies (Policies)	3 Months Ended
Summary of Significant Accounting Policies (Policies)	Mar. 31, 2019
Accounting Policies [Abstract]
Leases - Lessee Accounting Policy	Leases - Lessee accounting policy For the periods beginning January 1, 2019, right-of-use (“ROU”) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date of a lease (the “commencement date”) based on the present value of lease payments over the lease term. We determine if an arrangement is a lease at inception. Operating leases are included in Other assets, Accrued liabilities, and Other liabilities in our Consolidated and Combined Balance Sheets. No finance leases have been recognized. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Variable lease payments are expensed in the period in which they occur. We have lease agreements with lease and non-lease components, which are generally accounted for separately. For machinery and equipment, we account for the lease and non-lease components as a single lease component. We account for short-term leases by recognizing lease payments in net income on a straight-line basis over the lease term and will not recognize any ROU assets and lease liabilities on the Consolidated and Combined Balance Sheet. For the periods prior to January 1, 2019, we accounted for leases in accordance with ASC 840.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements Effective January 1, 2019, the Company adopted the new lease accounting standard using the modified retrospective transition option of applying the new standard at the adoption date while electing not to recast comparative periods in the transition. In addition, we elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed us to carry forward the historical lease classification. In adopting the new leases standard, the Company has applied the practical expedients as per ASC 842-10-65-1(f) and (g). Adoption of the new standard resulted in the recording of additional lease assets and lease liabilities of $34 million as of January 1, 2019. The adoption of this standard did not have a material impact related to existing leases and as a result, a cumulative-effect adjustment was not recorded. In February 2018, the FASB issued guidance that allows for an entity to elect to reclassify the income tax effects on items within Accumulated other comprehensive income resulting from The Tax Cuts and Jobs Act (“Tax Act”) to retained earnings. The guidance is effective for fiscal years beginning after December 15, 2018. Upon adoption, the Company did not elect to reclassify the stranded income tax effects of the Tax Act from accumulated other comprehensive income to retained earnings.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13), which requires measurement and recognition of expected credit losses for financial assets held. ASU 2016-13 will be effective for us in our first quarter of fiscal 2020, and earlier adoption is permitted beginning in the first quarter of fiscal 2019. We are currently evaluating the impact of the guidance on our Consolidated and Combined Financial Statements.

Background and Revision of Previously Issued Consolidated and Combined Interim Financial Statements for the Three Months Ended March 31, 2018 (Tables)

3 Months Ended

Mar. 31, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Summary of Each Financial Statement Line Item Affected by the Revision

The following tables identify each financial statement line item affected by the revision.

	Three Months Ended, March 31, 2018
Unaudited Consolidated and Combined Interim Statement of Operations (Millions)	Previously Reported			Adjustment			As Revised
	Unaudited			Unaudited			Unaudited
Other expense, net	$	44		$	(2	)	$	42
Income before taxes	$	111		$	2		$	113
Tax expense	$	55		$	—		$	55
Net income	$	56		$	2		$	58

	Three Months Ended, March 31, 2018
Unaudited Consolidated and Combined Interim Statement of Comprehensive Income (Millions)	Previously Reported			Adjustment			As Revised
	Unaudited			Unaudited			Unaudited
Net Income	$	56		$	2		$	58
Comprehensive (loss) income	$	(128	)	$	2		$	(126	)

	Three Months Ended, March 31, 2018
	Unaudited			Unaudited			Unaudited
Unaudited Consolidated and Combined Interim Statement of Cash Flows (Millions)	Previously Reported			Adjustment			As Revised
Net Income	$	56		$	2		$	58
Changes in assets and liabilities: Asbestos-related liabilities	$	4		$	(2	)	$	2
Net cash provided by operating activities	$	12		$	—		$	12
Net increase in Invested deficit	$	812		$	—		$	812
Net cash (used for) provided by financing activities	$	(163	)	$	—		$	(163	)

Related Party Transactions with Honeywell (Tables)

3 Months Ended

Mar. 31, 2019

Summary of Components of Net Transfers to and from Honeywell

The components of the net transfers to and from Honeywell for the three months ended March 31, 2018 are as follows:

	Three Months Ended March 31,
	2018
General financing activities	$	1,841
Distribution to Former Parent		(799	)
Unbilled corporate allocations		29
Stock compensation expense and other compensation awards		7
Pension expense		2
Total net decrease in Invested deficit	$	1,080

Revenue Recognition and Contracts with Customers (Tables)

3 Months Ended

Mar. 31, 2019

Revenue From Contract With Customer [Abstract]

Disaggregation of Revenue

Sales by region (determined based on country of shipment) and channel are as follows:

	Three months ended March 31, 2019
	OEM		Aftermarket		Other		Total
United States	$	83	$	45	$	1	$	129
Europe		429		37		12		478
Asia		199		13		7		219
Other International		4		5		—		9
	$	715	$	100	$	20	$	835

	Three months ended March 31, 2018⁽¹⁾
	OEM		Aftermarket		Other		Total
United States	$	89	$	43	$	1	$	133
Europe	463		41		17		521
Asia	230		12		8		250
Other International	5		6			—	11
	$	787	$	102	$	26	$	915

(1)	The revenue information was previously disaggregated between OEM and Aftermarket and is now disaggregated between OEM, Aftermarket, and Other. As a result, the prior period presented was recast to conform to the current year presentation.

Summary of Contract Assets and Liabilities

The following table summarizes our contract assets and liabilities balances:

	2019
Contract assets—January 1	$	5
Contract assets—March 31		6
Change in contract assets—Increase/(Decrease)	$	1
Contract liabilities—January 1	$	(2	)
Contract liabilities—March 31		(2	)
Change in contract liabilities—(Increase)/Decrease	$	—

Research and Development (Tables)

3 Months Ended

Mar. 31, 2019

Research And Development [Abstract]

Summary of Research and Development Activities

	Three Months Ended March 31,
	2019		2018
Research and development costs	$	32	$	31
Engineering-related expenses		3		2
	$	35	$	33

Other Expenses, Net (Tables)

3 Months Ended

Mar. 31, 2019

Other Income And Expenses [Abstract]

Schedule of Other Operating Cost and Expense

	Three Months Ended March 31,
	2019		2018
Indemnification related — post Spin-Off	$	19	$	—
Asbestos related, net of probable insurance recoveries		—		41
Environmental remediation, non-active sites		—		1
	$	19	$	42

Accounts, Notes and Other Receivables—Net (Tables)

3 Months Ended

Mar. 31, 2019

Receivables [Abstract]

Schedule of Accounts, Notes and Other Receivables Net

	March 31, 2019			December 31, 2018
Trade receivables	$	641		$	593
Notes receivables		77			93
Other receivables		77			67
	$	795		$	753
Less—Allowance for doubtful accounts		(5	)		(3	)
	$	790		$	750

Inventories-Net (Tables)

3 Months Ended

Mar. 31, 2019

Inventory Disclosure [Abstract]

Summary of Inventories

	March 31, 2019			December 31, 2018
Raw materials	$	112		$	112
Work in process		20			19
Finished products		72			64
	$	204		$	195
Less—Reserves		(23	)		(23	)
	$	181		$	172

Other Assets (Tables)

3 Months Ended

Mar. 31, 2019

Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]

Schedule of Other Assets

	March 31,		December 31,
	2019		2018
Advanced discounts to customers, non-current	$	53	$	56
Operating right-of-use assets (Note 13)		37		—
Undesignated cross-currency swap at fair value		25		16
Other		7		8
	$	122	$	80

Accrued Liabilities (Tables)

3 Months Ended

Mar. 31, 2019

Accrued Liabilities Current [Abstract]

Summary of Accrued Liabilities

	March 31, 2019		December 31, 2018
Customer pricing reserve	$	115	$	107
Compensation, benefit and other employee related		60		71
Repositioning		7		15
Product warranties and performance guarantees		35		32
Taxes		106		113
Advanced discounts from suppliers, current		18		17
Customer advances and deferred income^(a)		23		14
Accrued interest		11		6
Short-term lease liability (Note 13)		9		—
Other (primarily operating expenses)		49		51
	$	433	$	426

(a)	Customer advances and deferred income include $2 million of contract liabilities as of March 31, 2019 and December 31, 2018. See Note 4 Revenue Recognition and Contracts with Customers.

Summary of Expenses Related to the Repositioning Accruals

	Severance Costs			Exit Costs		Total
Balance at December 31, 2017	$	53		$	7	$	60
Charges		2			—		2
Usage—cash		(3	)		—		(3	)
Foreign currency translation		2			—		2
Balance at March 31, 2018	$	54		$	7	$	61

	Severance Costs			Exit Costs			Total
Balance at December 31, 2018	$	13		$	2		$	15
Charges		1			—			1
Usage—cash		(2	)		(2	)		(4	)
Adjustments and reclassifications		(6	)		1			(5	)
Foreign currency translation		—			—			—
Balance at March 31, 2019	$	6		$	1		$	7

Other Liabilities (Tables)

3 Months Ended

Mar. 31, 2019

Other Liabilities Disclosure [Abstract]

Schedule of Other Liabilities

	March 31,		December 31,
	2019		2018
Pension and other employee related	$	69	$	71
Advanced discounts from suppliers		61		63
Uncertain tax positions		63		59
Long-term lease liability (Note 13)		27		—
Other		22		17
	$	242	$	210

Leases (Tables)

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

Summary of Components of Lease Expense

The components of lease expense are as follows:

Three Months Ended

March 31, 2019

Operating lease cost

Summary of Supplemental Cash Flow Information Related to Operating Leases

Supplemental cash flow information related to operating leases is follows:

	Three Months Ended March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:	$
Operating cash outflows from operating leases		3
Right-of-use assets obtained in exchange for lease obligations:
Operating leases		5

Summary of Supplemental Balance Sheet Information Related to Operating Leases

Supplemental balance sheet information related to operating leases is follows:

	March 31, 2019
Other assets	$	37
Accrued liabilities		9
Other liabilities		27

		March 31, 2019
Weighted-average lease term		6.45
Weighted-average discount rate		6.34

Schedule of Maturities of Operating Lease Liabilities

Maturities of operating lease liabilities were as follows:

	March 31, 2019
2019	$	9
2020		8
2021		5
2022		5
2023		4
Thereafter		13
Total lease payments		44
Less imputed interest		(8	)
	$	36

Schedule of Future Minimum Lease Payments Under Operating Leases in Accordance with ASC 840

	December 31, 2018
2019	$	12
2020		8
2021		5
2022		4
2023		4
Thereafter		15
	$	48

Financial Instruments and Fair Value Measures (Tables)

3 Months Ended

Mar. 31, 2019

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Summary of Financial Assets and Liabilities Accounted for at Fair Value on Recurring Basis

The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2019 and December 31, 2018:

					Fair Value
	Notional Amounts				Assets					Liabilities
	March 31, 2019		December 31, 2018		March 31, 2019		December 31, 2018			March 31, 2019		December 31, 2018
Designated forward currency exchange contracts	$	257	$	—	$	3	$	—	^(b)	$	—	$	—
Undesignated instruments:
Undesignated cross-currency swap		423		425		25		16	^(a)		—		—
Undesignated forward currency exchange contracts		287		413		2		4	^(b)		1		1	^(c)
		710		838		27		20			1		1
	$	967	$	838	$	30	$	20		$	1	$	1

(a)

Recorded within Other assets in the Company’s Consolidated and Combined Balance Sheets

(b)

Recorded within Other current assets in the Company’s Consolidated and Combined Balance Sheets

(c)

Recorded within Accrued liabilities in the Company’s Consolidated and Combined Balance Sheets

Summary of Financial Assets and Liabilities Not Carried at Fair Value

The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:

	March 31, 2019
	Carrying Value		Fair Value
Long-term debt and related current maturities	$	1,565	$	1,564

Accumulated Other Comprehensive Income (Loss) (Tables)

3 Months Ended

Mar. 31, 2019

Accumulated Other Comprehensive Income Loss Net Of Tax [Abstract]

Summary of Changes in Accumulated Other Comprehensive Income (Loss) by Component

Changes in Accumulated Other Comprehensive Income (Loss) by Component

	Foreign Exchange Translation Adjustment			Changes in Fair Value of Effective Cash Flow Hedges			Pension Adjustments			Total Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2017	$	284		$	(35	)	$	(11	)	$	238
Other comprehensive income (loss) before reclassifications		(177	)		(19	)		—			(196	)
Amounts reclassified from accumulated other comprehensive income (loss)		—			12			—			12
Net current period other comprehensive income (loss)		(177	)		(7	)		—			(184	)
Balance at March 31, 2018	$	107		$	(42	)	$	(11	)	$	54

	Foreign Exchange Translation Adjustment		Changes in Fair Value of Effective Cash Flow Hedges		Pension Adjustments			Total Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2018	$	86	$	—	$	(13	)	$	73
Other comprehensive income (loss) before reclassifications		59		3		—			62
Amounts reclassified from accumulated other comprehensive income (loss)		—		—		1			1
Net current period other comprehensive income (loss)		59		3		1			63
Balance at March 31, 2019	$	145	$	3	$	(12	)	$	136

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Earnings Per Share

The details of the earnings per share calculations for the three months ended March 31, 2019 and 2018 are as follows:

	Three Months Ended March 31,
	2019		2018
Basic
Net Income	$	73	$	58
Weighted average common shares outstanding		74,229,627		74,070,852
EPS – Basic	$	0.98	$	0.78

	Three Months Ended March 31,
	2019		2018
Diluted
Net Income	$	73	$	58
Weighted average common shares outstanding – Basic		74,229,627		74,070,852
Dilutive effect of unvested RSUs and other contingently issuable shares		1,149,601		—
Weighted average common shares outstanding – Diluted		75,379,228		74,070,852
EPS – Diluted	$	0.97	$	0.78

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2019

Commitments And Contingencies Disclosure [Abstract]

Summary of Obligation Payable to Honeywell

The following table summarizes our Obligation payable to Honeywell related to these agreements:

	2019
	Asbestos and environmental			Tax Matters			Total
Beginning of year	$	1,244		$	282		$	1,526
Accrual for update to estimated liability		—			2			2
Legal fees expensed		15			—			15
Payments to Honeywell		(38	)		—			(38	)
Currency translation adjustment		(25	)		(6	)		(31	)
End of period	$	1,196		$	278		$	1,474

Current		106			18			124
Non-current		1,090			260			1,350
Total	$	1,196		$	278		$	1,474

Summary of Asbestos Claim Activity

The following tables present information regarding Bendix related asbestos claims activity:

	Three Months Ended March 31,			Year Ended December 31,
Claims Activity	2019			2018
Claims Unresolved at the beginning of the period		6,209			6,280
Claims Filed		631			2,430
Claims Resolved		(626	)		(2,501	)
Claims Unresolved at the end of the period		6,214			6,209

	Three Months Ended March 31,		Years Ended December 31,
Disease Distribution of Unresolved Claims	2019		2018
Mesothelioma and Other Cancer Claims		3,028		2,949
Nonmalignant Claims		3,186		3,260
Total Claims		6,214		6,209

Summary of Average Resolutions Per Claim Excluding Legal Costs

Honeywell has experienced average resolutions per claim excluding legal costs as follows:

	Years Ended December 31,
	2018		2017		2016		2015		2014
			(in whole dollars)
Malignant claims	$	55,300	$	56,000	$	44,000	$	44,000	$	53,500
Nonmalignant claims	$	4,700	$	2,800	$	4,485	$	100	$	120

Pension Benefits (Tables)

3 Months Ended

Mar. 31, 2019

Compensation And Retirement Disclosure [Abstract]

Summary of Net Periodic Benefit Cost

Net periodic benefit costs for our significant defined benefit plans include the following components:

	Three Months Ended
	U.S. Plans March 31,			Non-U.S. Plans⁽¹⁾ March 31,
	2019			2019			2018
Service cost		—		1			$	1
Interest cost	1			1				—
Expected return on plan assets		(1	)		(1	)		(1	)
Amortization of prior service (credit)		—			—			—
		—		1			$	—

(1)	For the periods prior to the Spin-Off, only the pension plan in Ireland is reflected as a non-U.S. defined benefit pension plan as all other pension plans were accounted for as multiemployer plans. Following the Spin-Off, the defined benefit pension plan in Switzerland is also reflected.

China Variable Interest Entity (Tables)

3 Months Ended

Mar. 31, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Schedule of Consolidated Assets and Liabilities

The following table summarizes the consolidated assets and liabilities of Garrett China:

	March 31,		December 31,
	2019		2018
	(Dollars in millions)
ASSETS
Current assets:
Cash and cash equivalents	$	114	$	70
Accounts, notes and other receivables—net		211		224
Inventories—net		21		19
Total current assets		346		313
Property, plant and equipment—net		68		67
Deferred income taxes		21		20
Other assets		1		1
Total assets	$	436	$	401
LIABILITIES
Current liabilities:
Accounts payable	$	261	$	261
Accrued liabilities		83		77
Total current liabilities		344		338
Other liabilities		12		13
Total liabilities	$	356	$	351

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details

Background and Revision of Previously Issued Consolidated and Combined Interim Financial Statements for the Three Months Ended March 31, 2018 - Additional Information (Details) - Honeywell shares in Millions	Oct. 01, 2018 shares
Background And Revision Of Previously Issued Consolidated And Combined Interim Financial Statements [Line Items]
Conversion common stock shareowner received ratio	0.1
Description of conversion common stock shareowner received ratio	Each Honeywell stockholder of record received one share of Garrett common stock for every 10 shares of Honeywell common stock held on the record date.
Shares of Garrett common stock distributed	74
Garrett Motion Inc.
Background And Revision Of Previously Issued Consolidated And Combined Interim Financial Statements [Line Items]
Pro rata distribution of outstanding shares, percentage	100.00%

Background and Revision of Previously Issued Consolidated and Combined Interim Financial Statements for the Three Months Ended March 31, 2018 - Summary of Each Financial Statement Line Item Affected by the Revision (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Background And Revision Of Previously Issued Consolidated And Combined Interim Financial Statements [Line Items]
Other expense, net (Note 6)	$ 19	$ 42
Income before taxes	97	113
Tax expense	24	55
Net income	73	58
Comprehensive (loss) income	136	(126)
Net income	73	58
Changes in assets and liabilities: Asbestos-related liabilities		2
Net cash provided by operating activities	36	12
Net increase in Invested deficit		812
Net cash (used for) provided by financing activities	$ (5)	(163)
Previously Reported Unaudited
Background And Revision Of Previously Issued Consolidated And Combined Interim Financial Statements [Line Items]
Other expense, net (Note 6)		44
Income before taxes		111
Tax expense		55
Net income		56
Comprehensive (loss) income		(128)
Net income		56
Changes in assets and liabilities: Asbestos-related liabilities		4
Net cash provided by operating activities		12
Net increase in Invested deficit		812
Net cash (used for) provided by financing activities		(163)
Adjustment Unaudited
Background And Revision Of Previously Issued Consolidated And Combined Interim Financial Statements [Line Items]
Other expense, net (Note 6)		(2)
Income before taxes		2
Net income		2
Comprehensive (loss) income		2
Net income		2
Changes in assets and liabilities: Asbestos-related liabilities		$ (2)

Basis of Presentation - Additional Information (Details) - USD ($)		3 Months Ended
	Sep. 12, 2018	Mar. 31, 2019
Indemnification and Reimbursement Agreement
Basis Of Presentation [Line Items]
Agreement termination date	Dec. 31, 2048
Agreement termination description	The Indemnification and Reimbursement Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement.	The Indemnification and Reimbursement Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement.
Bendix
Basis Of Presentation [Line Items]
Percentage of asbestos and environmental liabilities liable to pay	100.00%	100.00%
Honeywell \| Indemnification and Reimbursement Agreement
Basis Of Presentation [Line Items]
Percentage of net insurance receipts	90.00%
Honeywell \| Indemnification and Reimbursement Agreement \| Maximum
Basis Of Presentation [Line Items]
Liability for asbestos and environmental claims maximum amount converted into euros	$ 25,000,000
Honeywell \| Bendix \| Indemnification and Reimbursement Agreement
Basis Of Presentation [Line Items]
Percentage of asbestos and environmental liabilities liable to pay	90.00%

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Millions	Mar. 31, 2019	Jan. 01, 2019
Significant Accounting Policies [Line Items]
Operating lease right-of-use assets	$ 37
Operating lease, liabilities	$ 36
ASU 2016-02
Significant Accounting Policies [Line Items]
Operating lease right-of-use assets		$ 34
Operating lease, liabilities		$ 34

Related Party Transactions with Honeywell - Additional Information (Details) - Honeywell International Inc $ in Millions	3 Months Ended
	Mar. 31, 2018 USD ($)
Notes Receivables \| Maximum
Related Party Transaction [Line Items]
Interest income received for related party	$ 1
Notes Payable
Related Party Transaction [Line Items]
Interest expense incurred for related party	1
Selling, General and Administrative Expenses
Related Party Transaction [Line Items]
General corporate expenses included within selling, general and administrative expenses	$ 29

Related Party Transactions with Honeywell - Summary of Components of Net Transfers to and from Honeywell (Details) $ in Millions	3 Months Ended
	Mar. 31, 2018 USD ($)
Related Party Transaction [Line Items]
Total net decrease in Invested deficit	$ 1,080
Honeywell International Inc
Related Party Transaction [Line Items]
General financing activities	1,841
Distribution to Former Parent	(799)
Unbilled corporate allocations	29
Stock compensation expense and other compensation awards	7
Pension expense	2
Total net decrease in Invested deficit	$ 1,080

Revenue Recognition and Contracts with Customers - Summary of Net Sales by Region and Channel (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Disaggregation Of Revenue [Line Items]
Net sales	$ 835	$ 915
OEM
Disaggregation Of Revenue [Line Items]
Net sales	715	787
Aftermarket
Disaggregation Of Revenue [Line Items]
Net sales	100	102
Other
Disaggregation Of Revenue [Line Items]
Net sales	20	26
United States
Disaggregation Of Revenue [Line Items]
Net sales	129	133
United States \| OEM
Disaggregation Of Revenue [Line Items]
Net sales	83	89
United States \| Aftermarket
Disaggregation Of Revenue [Line Items]
Net sales	45	43
United States \| Other
Disaggregation Of Revenue [Line Items]
Net sales	1	1
Europe
Disaggregation Of Revenue [Line Items]
Net sales	478	521
Europe \| OEM
Disaggregation Of Revenue [Line Items]
Net sales	429	463
Europe \| Aftermarket
Disaggregation Of Revenue [Line Items]
Net sales	37	41
Europe \| Other
Disaggregation Of Revenue [Line Items]
Net sales	12	17
Asia
Disaggregation Of Revenue [Line Items]
Net sales	219	250
Asia \| OEM
Disaggregation Of Revenue [Line Items]
Net sales	199	230
Asia \| Aftermarket
Disaggregation Of Revenue [Line Items]
Net sales	13	12
Asia \| Other
Disaggregation Of Revenue [Line Items]
Net sales	7	8
Other International
Disaggregation Of Revenue [Line Items]
Net sales	9	11
Other International \| OEM
Disaggregation Of Revenue [Line Items]
Net sales	4	5
Other International \| Aftermarket
Disaggregation Of Revenue [Line Items]
Net sales	$ 5	$ 6

Revenue Recognition and Contracts with Customers - Summary of Contract Assets and Liabilities (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Contract With Customer Asset And Liability [Abstract]
Contract assets—January 1	$ 5
Contract assets—March 31	6
Change in contract assets—Increase/(Decrease)	1
Contract liabilities—January 1	(2)
Contract liabilities—March 31	$ (2)

Research and Development - Summary of Research and Development Activities (Details) - Cost of Goods Sold - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Research And Development Arrangement Contract To Perform For Others [Line Items]
Research and development expense, total	$ 35	$ 33
Research and Development Costs
Research And Development Arrangement Contract To Perform For Others [Line Items]
Research and development expense, total	32	31
Engineering-Related Expenses
Research And Development Arrangement Contract To Perform For Others [Line Items]
Research and development expense, total	$ 3	$ 2

Other Expense, Net - Schedule of Other Operating Cost and Expense (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Other Income And Expenses [Abstract]
Indemnification related — post Spin-Off	$ 19
Asbestos related, net of probable insurance recoveries		$ 41
Environmental remediation, non-active sites		1
Other operating income (expense), net	$ 19	$ 42

Income Taxes - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Tax Disclosure [Abstract]
Tax expense		$ 25
U.S. federal statutory income tax rate	21.00%	21.00%

Accounts, Notes and Other Receivables Net - Schedule of Accounts, Notes and Other Receivables Net (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Receivables [Abstract]
Trade receivables	$ 641	$ 593
Notes receivables	77	93
Other receivables	77	67
Accounts, notes and other receivables, gross	795	753
Less—Allowance for doubtful accounts	(5)	(3)
Accounts, notes and other receivables, net	$ 790	$ 750

Accounts, Notes and Other Receivables Net - Additional Information (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Receivables [Abstract]
Unbilled balances	$ 20	$ 5
Unbilled contracts assets	$ 6	$ 5

Inventories-Net - Summary of Inventories (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Inventory Combining Work In Process And Raw Materials Alternative Gross [Abstract]
Raw materials	$ 112	$ 112
Work in process	20	19
Finished products	72	64
Inventory, gross	204	195
Less—Reserves	(23)	(23)
Inventories	$ 181	$ 172

Other Assets - Schedule of Other Assets (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Other Assets [Line Items]
Advanced discounts to customers, non-current	$ 53	$ 56
Operating right-of-use assets (Note 13)	$ 37
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssetsNoncurrent	us-gaap:OtherAssetsNoncurrent
Other	$ 7	$ 8
Total	122	80
Undesignated as Hedging [Member] \| Cross-currency Swap [Member]
Other Assets [Line Items]
Undesignated cross-currency swap at fair value	$ 25	$ 16

Accrued Liabilities - Summary of Accrued Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Accrued Liabilities Current [Abstract]
Customer pricing reserve	$ 115	$ 107
Compensation, benefit and other employee related	60	71
Repositioning	7	15
Product warranties and performance guarantees	35	32
Taxes	106	113
Advanced discounts from suppliers, current	18	17
Customer advances and deferred income	23	14
Accrued interest	11	6
Short-term lease liability (Note 13)	9
Other (primarily operating expenses)	49	51
Accrued Liabilities	$ 433	$ 426

Accrued Liabilities - Summary of Accrued Liabilities (Parenthetical) (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Accrued Liabilities Current [Abstract]
Contract liabilities	$ 2	$ 2

Accrued Liabilities - Summary of Expenses Related to the Repositioning Accruals (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Restructuring Cost And Reserve [Line Items]
Balance at beginning of period	$ 15	$ 60
Charges	1	2
Usage—cash	(4)	(3)
Adjustments and reclassifications	(5)
Foreign currency translation		2
Balance at end of period	7	61
Severance Costs
Restructuring Cost And Reserve [Line Items]
Balance at beginning of period	13	53
Charges	1	2
Usage—cash	(2)	(3)
Adjustments and reclassifications	(6)
Foreign currency translation		2
Balance at end of period	6	54
Exit Costs
Restructuring Cost And Reserve [Line Items]
Balance at beginning of period	2	7
Usage—cash	(2)	0
Adjustments and reclassifications	1
Balance at end of period	$ 1	$ 7

Other Liabilities - Schedule of Other Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Other Liabilities Disclosure [Abstract]
Pension and other employee related	$ 69	$ 71
Advanced discounts from suppliers	61	63
Uncertain tax positions	63	59
Long-term lease liability (Note 13)	27
Other	22	17
Other Liabilities	$ 242	$ 210

Leases - Additional Information (Details)	3 Months Ended
Leases - Additional Information (Details)	Mar. 31, 2019
Lessee Lease Description [Line Items]
Operating lease, option to extend	true
Operating lease, option to extend, description	some of which include options to extend the leases for up to two years
Operating lease, option to terminate	true
Operating lease, option to terminate, description	some of which include options to terminate the leases within the year
Maximum
Lessee Lease Description [Line Items]
Operating lease, remaining lease terms	12 years
Operating lease, options to extend, years	2 years

Leases - Summary of Components of Lease Expense (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Leases [Abstract]
Operating lease cost	$ 3
Lease cost, total	$ 3

Leases - Summary of Supplemental Cash Flow Information Related to Operating Leases (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Leases [Abstract]
Operating cash outflows from operating leases	$ 3
Right-of-use assets obtained in exchange for lease obligations, operating leases	$ 5

Leases - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Leases [Abstract]
Other assets	$ 37
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssetsNoncurrent	us-gaap:OtherAssetsNoncurrent
Accrued liabilities	$ 9
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	us-gaap:AccruedLiabilitiesCurrent
Other liabilities	$ 27
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	us-gaap:OtherLiabilitiesNoncurrent
Weighted-average lease term	6 years 5 months 12 days
Weighted-average discount rate	6.34%

Leases - Schedule of Maturities of Operating Lease Liabilities (Details) $ in Millions	Mar. 31, 2019 USD ($)
Leases [Abstract]
2019	$ 9
2020	8
2021	5
2022	5
2023	4
Thereafter	13
Total lease payments	44
Less imputed interest	(8)
Operating lease, liabilities	$ 36

Leases - Schedule of Future Minimum Lease Payments Under Operating Leases in Accordance with ASC 840 (Details) $ in Millions	Dec. 31, 2018 USD ($)
Leases [Abstract]
2019	$ 12
2020	8
2021	5
2022	4
2023	4
Thereafter	15
Total	$ 48

Financial Instruments and Fair Value Measures - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative, aggregate gross notional amount	$ 967,000,000	$ 838,000,000
Cross-currency Swap Contract
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Floating cross-currency swap contract entered date	Sep. 27, 2018
Floating cross-currency swap contract maturity date	Sep. 27, 2025
Cross-currency Swap Contract \| Nonoperating Expense (Income)
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Gains on derivative instrument	$ 8,000,000

Financial Instruments and Fair Value Measures - Summary of Financial Assets and Liabilities Accounted for at Fair Value on Recurring Basis (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	$ 967,000,000	$ 838,000,000
Undesignated as Hedging [Member] \| Cross-currency Swap [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Vale, Assets	25,000,000	16,000,000
Fair Value Measurements Recurring [Member] \| Significant Observable Inputs (Level 2) [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	967,000,000	838,000,000
Fair Vale, Assets	30,000,000	20,000,000
Fair Value, Liabilities	1,000,000	1,000,000
Fair Value Measurements Recurring [Member] \| Significant Observable Inputs (Level 2) [Member] \| Designated as Hedging [Member] \| Forward Currency Exchange Contracts [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	257,000,000
Fair Vale, Assets	3,000,000
Fair Value Measurements Recurring [Member] \| Significant Observable Inputs (Level 2) [Member] \| Undesignated as Hedging [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	710,000,000	838,000,000
Fair Vale, Assets	27,000,000	20,000,000
Fair Value, Liabilities	1,000,000	1,000,000
Fair Value Measurements Recurring [Member] \| Significant Observable Inputs (Level 2) [Member] \| Undesignated as Hedging [Member] \| Forward Currency Exchange Contracts [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	287,000,000	413,000,000
Fair Vale, Assets	2,000,000	4,000,000
Fair Value, Liabilities	1,000,000	1,000,000
Fair Value Measurements Recurring [Member] \| Significant Observable Inputs (Level 2) [Member] \| Undesignated as Hedging [Member] \| Cross-currency Swap [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	423,000,000	425,000,000
Fair Vale, Assets	$ 25,000,000	$ 16,000,000

Financial Instruments and Fair Value Measures - Summary of Financial Assets and Liabilities Not Carried at Fair Value (Details) $ in Millions	Mar. 31, 2019 USD ($)
Carrying Value [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Long-term debt and related current maturities	$ 1,565
Fair Value [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Long-term debt and related current maturities	$ 1,564

Accumulated Other Comprehensive Income (Loss) - Summary of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018	Dec. 31, 2017
Accumulated Other Comprehensive Income Loss [Line Items]
Balance beginning of period	$ (2,452)	$ (1,241)	$ (2,593)	$ (2,195)
Total other comprehensive (loss) income, net of tax	63	(184)
Foreign Exchange Translation Adjustment
Accumulated Other Comprehensive Income Loss [Line Items]
Balance beginning of period	145	107	86	284
Other comprehensive income (loss) before reclassifications	59	(177)
Total other comprehensive (loss) income, net of tax	59	(177)
Changes in Fair Value of Effective Cash Flow Hedges
Accumulated Other Comprehensive Income Loss [Line Items]
Balance beginning of period	3	(42)		(35)
Other comprehensive income (loss) before reclassifications	3	(19)
Amounts reclassified from accumulated other comprehensive income (loss)		12
Total other comprehensive (loss) income, net of tax	3	(7)
Pension Adjustments
Accumulated Other Comprehensive Income Loss [Line Items]
Balance beginning of period	(12)	(11)	(13)	(11)
Amounts reclassified from accumulated other comprehensive income (loss)	1
Total other comprehensive (loss) income, net of tax	1
Total Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income Loss [Line Items]
Balance beginning of period	136	54	$ 73	$ 238
Other comprehensive income (loss) before reclassifications	62	(196)
Amounts reclassified from accumulated other comprehensive income (loss)	1	12
Total other comprehensive (loss) income, net of tax	$ 63	$ (184)

Earnings Per Share - Additional Information (Details) - shares	3 Months Ended	9 Months Ended
	Mar. 31, 2019	Sep. 30, 2018	Dec. 31, 2018	Oct. 01, 2018
Shares of common stock distributed	74,634,286		74,070,852
Basic and diluted shares		74,070,852
Weighted number of stock options excluded from computations	146,652
Honeywell \| Exit Costs
Shares of common stock distributed				74,070,852

Earnings Per Share - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Basic
Net income	$ 73	$ 58
Weighted average common shares outstanding – Basic	74,229,627	74,070,852
EPS – Basic	$ 0.98	$ 0.78
Diluted
Net income	$ 73	$ 58
Weighted average common shares outstanding – Basic	74,229,627	74,070,852
Dilutive effect of unvested RSUs and other contingently issuable shares	1,149,601
Weighted average common shares outstanding – Diluted	75,379,228	74,070,852
EPS – Diluted	$ 0.97	$ 0.78

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Commitments and Contingencies - Additional Information (Details) $ in Millions				3 Months Ended
	Apr. 01, 2019 USD ($)	Oct. 01, 2018 USD ($) Installment	Sep. 12, 2018 USD ($)	Mar. 31, 2019 USD ($)
Indemnification and Reimbursement Agreement
Loss Contingencies [Line Items]
Loss contingency payable			$ 175
Minimum amount agreed to maintain for termination			$ 25
Agreement termination description			The Indemnification and Reimbursement Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement.	The Indemnification and Reimbursement Agreement provides that the agreement will terminate upon the earlier of (x) December 31, 2048 or (y) December 31st of the third consecutive year during which certain amounts owed to Honeywell during each such year were less than $25 million as converted into Euros in accordance with the terms of the agreement.
Honeywell \| Tax Matters Agreement
Loss Contingencies [Line Items]
Aggregate payments connection with mandatory transition tax		$ 240
Number of annual installments \| Installment		5
Mandatory transition tax rate first installment		8.00%
Mandatory transition tax rate second installment		8.00%
Mandatory transition tax rate third installment		15.00%
Mandatory transition tax rate fourth installment		20.00%
Mandatory transition tax rate fifth installment		25.00%
Honeywell \| Tax Matters Agreement \| Subsequent Event
Loss Contingencies [Line Items]
Payment to Honeywell	$ 18
Honeywell \| Indemnification and Reimbursement Agreement
Loss Contingencies [Line Items]
Percentage of net insurance receipts			90.00%
Payment made in connection with the Indemnification and Reimbursement Agreement				$ 38
Description of indemnification agreement				As of the Spin-Off date of October 1, 2018, we are obligated to make payments to Honeywell in amounts equal to 90% of Honeywell’s asbestos-related liability payments and accounts payable, primarily related to the Bendix business in the United States, as well as certain environmental-related liability payments and accounts payable and non-United States asbestos-related liability payments and accounts payable, in each case related to legacy elements of the Business, including the legal costs of defending and resolving such liabilities, less 90% of Honeywell’s net insurance receipts and, as may be applicable, certain other recoveries associated with such liabilities. Pursuant to the terms of this Indemnification and Reimbursement Agreement, we are responsible for paying to Honeywell such amounts, up to a cap of an amount equal to the Euro-to-U.S. dollar exchange rate determined by Honeywell as of a date within two business days prior to the date of the Distribution (1.16977 USD = 1 EUR) equivalent of $175 million in respect of such liabilities arising in any given calendar year.
Bendix
Loss Contingencies [Line Items]
Percentage of asbestos and environmental liabilities liable to pay			100.00%	100.00%
Bendix \| Honeywell \| Indemnification and Reimbursement Agreement
Loss Contingencies [Line Items]
Percentage of asbestos and environmental liabilities liable to pay			90.00%

Commitments and Contingencies - Summary of Obligation Payable to Honeywell (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Loss Contingencies [Line Items]
Current	$ 124	$ 127
Non-current	1,350	$ 1,399
Honeywell
Loss Contingencies [Line Items]
Beginning of year	1,526
Accrual for update to estimated liability	2
Legal fees expensed	15
Payments to Honeywell	(38)
Currency translation adjustment	(31)
End of period	1,474
Current	124
Non-current	1,350
Total	1,474
Honeywell \| Asbestos and Environmental
Loss Contingencies [Line Items]
Beginning of year	1,244
Legal fees expensed	15
Payments to Honeywell	(38)
Currency translation adjustment	(25)
End of period	1,196
Current	106
Non-current	1,090
Total	1,196
Honeywell \| Tax Matters Agreement
Loss Contingencies [Line Items]
Beginning of year	282
Accrual for update to estimated liability	2
Currency translation adjustment	(6)
End of period	278
Current	18
Non-current	260
Total	$ 278

Commitments and Contingencies - Summary of Asbestos Claims Activity (Details) - Bendix - Claim	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Claims Activity
Claims Unresolved at the beginning of the period	6,209	6,280
Claims Filed	631	2,430
Claims Resolved	(626)	(2,501)
Claims Unresolved at the end of the period	6,214	6,209

Commitments and Contingencies - Summary of Asbestos Disease Distribution of Unresolved Claims (Details) - Bendix - Claim	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Disease Distribution of Unresolved Claims
Mesothelioma and Other Cancer Claims	3,028	2,949
Nonmalignant Claims	3,186	3,260
Total Claims	6,214	6,209	6,280

Commitments and Contingencies - Summary of Average Resolutions Per Claim Excluding Legal Costs (Details) - $ / Claim	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Commitments And Contingencies Disclosure [Abstract]
Malignant claims	55,300	56,000	44,000	44,000	53,500
Nonmalignant claims	4,700	2,800	4,485	100	120

Pension Benefits - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Pension Benefits \| Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Expected pension contribution in the next fiscal year	$ 6
Pension contribution	$ 1
Shared Plan
Defined Benefit Plan Disclosure [Line Items]
Pension expense		$ 2

Pension Benefits - Summary of Net Periodic Benefit Cost (Details) - Pension Benefits - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 1
Expected return on plan assets	(1)
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	1	$ 1
Interest cost	1
Expected return on plan assets	(1)	$ (1)
Net periodic benefit costs	$ 1

China Variable Interest Entity - Additional Information (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Sep. 30, 2018	Mar. 31, 2019	Mar. 31, 2018
Variable Interest Entity [Line Items]
Net sales		$ 835	$ 915
Cost of goods sold		639	704
Selling, general and administrative expenses		60	63
Tax expense		24	55
Garrett China \| Variable Interest Entity, Primary Beneficiary
Variable Interest Entity [Line Items]
Variable interest ownership percentage	100.00%
Equity interests in exchange for shares of common stock issued	8,444,077
Net sales		116	130
Cost of goods sold		79	88
Selling, general and administrative expenses		3	2
Tax expense		$ 7	$ 10

China Variable Interest Entity - Schedule of Consolidated Assets and Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 207	$ 196	$ 311	$ 300
Accounts, notes and other receivables—net	790	750
Inventories—net	181	172
Property, plant and equipment—net	424	438
Deferred income taxes	159	165
Other assets	122	80
Current liabilities:
Accounts payable	881	916
Accrued liabilities	433	426
Other liabilities	242	210
Variable Interest Entity, Primary Beneficiary \| Garrett China
Current assets:
Cash and cash equivalents	114	70
Accounts, notes and other receivables—net	211	224
Inventories—net	21	19
Total current assets	346	313
Property, plant and equipment—net	68	67
Deferred income taxes	21	20
Other assets	1	1
Total assets	436	401
Current liabilities:
Accounts payable	261	261
Accrued liabilities	83	77
Total current liabilities	344	338
Other liabilities	12	13
Total liabilities	$ 356	$ 351